In a public-private partnership with a Canadian company, the initiative is being carried out by the Indian Institute of Integrated Medicine in the territory of Jammu and will contribute to the production of quality medicines for export to patients suffering from neuropathies, cancer, diabetes and epilepsy, the Minister of Science and Technology said during a tour of the center.

Singh described the agreement that gave life to the project as historic not only for the region of Jammu and Kashmir, but for the whole of India for the scientific contribution, and highlighted the role of biotechnology in this effort.

He also commended the work of the scientists in charge of the research, mainly those from the Indian Institute of Integrated Medicine.

Singh obtained first-hand information on the cultivation practices in the protected area and the research work being carried out on the plant.

He also visited the greenhouses with climate control facilities to improve the varieties according to the desired cannabinoid content.

According to the Indian minister, there are already medicines in other countries derived from the cannabis plant for the treatment of nausea and vomiting, neuropathic pain and epilepsy, among others.

mh/jav/osc/lrd